List of Excipients in API levothyroxine sodium
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing levothyroxine sodium
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| AbbVie Inc | SYNTHROID | levothyroxine sodium | 0074-4341 | ACACIA | |
| AbbVie Inc | SYNTHROID | levothyroxine sodium | 0074-4341 | FD&C YELLOW NO. 6 | |
| AbbVie Inc | SYNTHROID | levothyroxine sodium | 0074-4341 | LACTOSE MONOHYDRATE | |
| AbbVie Inc | SYNTHROID | levothyroxine sodium | 0074-4341 | MAGNESIUM STEARATE | |
| AbbVie Inc | SYNTHROID | levothyroxine sodium | 0074-4341 | POVIDONE | |
| AbbVie Inc | SYNTHROID | levothyroxine sodium | 0074-4341 | SUCROSE | |
| AbbVie Inc | SYNTHROID | levothyroxine sodium | 0074-4341 | TALC | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing levothyroxine sodium
Detailed excipient profiles for levothyroxine sodium
Excipient focus: ACACIA
levothyroxine sodium drug variants containing ACACIA
levothyroxine sodium drug variants not containing ACACIA
Excipient focus: AKA218
levothyroxine sodium drug variants containing AKA218
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | levothyroxine sodium | 50090-7565 |
| A-S Medication Solutions | levothyroxine sodium | 50090-7566 |
| >Company | >Ingredient | >NDC |
levothyroxine sodium drug variants not containing AKA218
Excipient focus: ALPHA-TOCOPHEROL
levothyroxine sodium drug variants containing ALPHA-TOCOPHEROL
| Company | Ingredient | NDC |
|---|---|---|
| Amneal Pharmaceuticals NY LLC | levothyroxine sodium | 69238-1163 |
| Amneal Pharmaceuticals NY LLC | levothyroxine sodium | 69238-1169 |
| >Company | >Ingredient | >NDC |
levothyroxine sodium drug variants not containing ALPHA-TOCOPHEROL
Excipient focus: ALUMINUM OXIDE
levothyroxine sodium drug variants containing ALUMINUM OXIDE
levothyroxine sodium drug variants not containing ALUMINUM OXIDE
Excipient focus: ANHYDROUS CITRIC ACID
levothyroxine sodium drug variants containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Provell Pharmaceuticals LLC | levothyroxine sodium | 72305-025 |
| >Company | >Ingredient | >NDC |
levothyroxine sodium drug variants not containing ANHYDROUS CITRIC ACID
Excipient focus: ARGININE
levothyroxine sodium drug variants containing ARGININE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | levothyroxine sodium | 24201-002 |
| >Company | >Ingredient | >NDC |
levothyroxine sodium drug variants not containing ARGININE
Excipient focus: BETADEX SULFOBUTYL ETHER SODIUM
levothyroxine sodium drug variants containing BETADEX SULFOBUTYL ETHER SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | levothyroxine sodium | 24201-002 |
| >Company | >Ingredient | >NDC |
levothyroxine sodium drug variants not containing BETADEX SULFOBUTYL ETHER SODIUM
Excipient focus: BLUE 1
levothyroxine sodium drug variants containing BLUE 1
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | levothyroxine sodium | 50090-6089 |
| A-S Medication Solutions | levothyroxine sodium | 50090-7565 |
| A-S Medication Solutions | levothyroxine sodium | 50090-7566 |
| >Company | >Ingredient | >NDC |
levothyroxine sodium drug variants not containing BLUE 1
Excipient focus: BUTYLATED HYDROXYANISOLE
levothyroxine sodium drug variants containing BUTYLATED HYDROXYANISOLE
levothyroxine sodium drug variants not containing BUTYLATED HYDROXYANISOLE
Excipient focus: BUTYLATED HYDROXYTOLUENE
levothyroxine sodium drug variants containing BUTYLATED HYDROXYTOLUENE
levothyroxine sodium drug variants not containing BUTYLATED HYDROXYTOLUENE
Excipient focus: CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE
levothyroxine sodium drug variants containing CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| DIRECT RX | levothyroxine sodium | 72189-173 |
| >Company | >Ingredient | >NDC |
levothyroxine sodium drug variants not containing CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE
Excipient focus: CALCIUM SULFATE DIHYDRATE
levothyroxine sodium drug variants containing CALCIUM SULFATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | levothyroxine sodium | 54868-4087 |
| Pfizer Laboratories Div Pfizer Inc | levothyroxine sodium | 60793-850 |
| >Company | >Ingredient | >NDC |
levothyroxine sodium drug variants not containing CALCIUM SULFATE DIHYDRATE
Excipient focus: CARMINIC ACID
levothyroxine sodium drug variants containing CARMINIC ACID
levothyroxine sodium drug variants not containing CARMINIC ACID
Excipient focus: CELLULOSE, MICROCRYSTALLINE
levothyroxine sodium drug variants containing CELLULOSE, MICROCRYSTALLINE
levothyroxine sodium drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: CI 15985
levothyroxine sodium drug variants containing CI 15985
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | levothyroxine sodium | 50090-7648 |
| A-S Medication Solutions | levothyroxine sodium | 50090-7649 |
| >Company | >Ingredient | >NDC |
levothyroxine sodium drug variants not containing CI 15985
Excipient focus: CI 42090
levothyroxine sodium drug variants containing CI 42090
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | levothyroxine sodium | 50090-7767 |
| >Company | >Ingredient | >NDC |
levothyroxine sodium drug variants not containing CI 42090
Excipient focus: CI 47005
levothyroxine sodium drug variants containing CI 47005
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | levothyroxine sodium | 50090-6573 |
| >Company | >Ingredient | >NDC |
levothyroxine sodium drug variants not containing CI 47005
Excipient focus: CI 73360
levothyroxine sodium drug variants containing CI 73360
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | levothyroxine sodium | 50090-6573 |
| >Company | >Ingredient | >NDC |
levothyroxine sodium drug variants not containing CI 73360
Excipient focus: CITRIC ACID MONOHYDRATE
levothyroxine sodium drug variants containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc | levothyroxine sodium | 52652-1950 |
| VistaPharm Inc | levothyroxine sodium | 66689-105 |
| Oliva Therapeutics LLC | levothyroxine sodium | 82685-360 |
| >Company | >Ingredient | >NDC |
levothyroxine sodium drug variants not containing CITRIC ACID MONOHYDRATE
Excipient focus: COLLOIDAL SILICON DIOXIDE
levothyroxine sodium drug variants containing COLLOIDAL SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Dispensing Solutions Inc | levothyroxine sodium | 66336-801 |
| >Company | >Ingredient | >NDC |
levothyroxine sodium drug variants not containing COLLOIDAL SILICON DIOXIDE
Excipient focus: CROSCARMELLOSE SODIUM
levothyroxine sodium drug variants containing CROSCARMELLOSE SODIUM
levothyroxine sodium drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: CROSPOVIDONE
levothyroxine sodium drug variants containing CROSPOVIDONE
levothyroxine sodium drug variants not containing CROSPOVIDONE
Excipient focus: D&C RED NO. 27
levothyroxine sodium drug variants containing D&C RED NO. 27
levothyroxine sodium drug variants not containing D&C RED NO. 27
Excipient focus: D&C RED NO. 27 ALUMINUM LAKE
levothyroxine sodium drug variants containing D&C RED NO. 27 ALUMINUM LAKE
levothyroxine sodium drug variants not containing D&C RED NO. 27 ALUMINUM LAKE
Excipient focus: D&C RED NO. 30
levothyroxine sodium drug variants containing D&C RED NO. 30
levothyroxine sodium drug variants not containing D&C RED NO. 30
Excipient focus: D&C YELLOW NO. 10
levothyroxine sodium drug variants containing D&C YELLOW NO. 10
levothyroxine sodium drug variants not containing D&C YELLOW NO. 10
Excipient focus: D&C YELLOW NO. 10 ALUMINUM LAKE
levothyroxine sodium drug variants containing D&C YELLOW NO. 10 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Preferred Pharmaceuticals Inc | levothyroxine sodium | 68788-8792 |
| Bryant Ranch Prepack | levothyroxine sodium | 71335-2538 |
| >Company | >Ingredient | >NDC |
levothyroxine sodium drug variants not containing D&C YELLOW NO. 10 ALUMINUM LAKE
Excipient focus: D&C YELLOW NO. 6
levothyroxine sodium drug variants containing D&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | levothyroxine sodium | 21695-748 |
| >Company | >Ingredient | >NDC |
levothyroxine sodium drug variants not containing D&C YELLOW NO. 6
Excipient focus: DIBASIC CALCIUM PHOSPHATE DIHYDRATE
levothyroxine sodium drug variants containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
levothyroxine sodium drug variants not containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
Excipient focus: EDETATE DISODIUM
levothyroxine sodium drug variants containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | levothyroxine sodium | 24201-002 |
| Viatris Specialty LLC | levothyroxine sodium | 49502-378 |
| >Company | >Ingredient | >NDC |
levothyroxine sodium drug variants not containing EDETATE DISODIUM
Excipient focus: FD&C BLUE NO. 1
levothyroxine sodium drug variants containing FD&C BLUE NO. 1
levothyroxine sodium drug variants not containing FD&C BLUE NO. 1
Excipient focus: FD&C BLUE NO. 1 ALUMINUM LAKE
levothyroxine sodium drug variants containing FD&C BLUE NO. 1 ALUMINUM LAKE
levothyroxine sodium drug variants not containing FD&C BLUE NO. 1 ALUMINUM LAKE
Excipient focus: FD&C BLUE NO. 1--ALUMINUM LAKE
levothyroxine sodium drug variants containing FD&C BLUE NO. 1--ALUMINUM LAKE
levothyroxine sodium drug variants not containing FD&C BLUE NO. 1--ALUMINUM LAKE
Excipient focus: FD&C BLUE NO. 2
levothyroxine sodium drug variants containing FD&C BLUE NO. 2
levothyroxine sodium drug variants not containing FD&C BLUE NO. 2
Excipient focus: FD&C BLUE NO. 2 ALUMINUM LAKE
levothyroxine sodium drug variants containing FD&C BLUE NO. 2 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Preferred Pharmaceuticals Inc | levothyroxine sodium | 68788-8792 |
| >Company | >Ingredient | >NDC |
levothyroxine sodium drug variants not containing FD&C BLUE NO. 2 ALUMINUM LAKE
Excipient focus: FD&C BLUE NO. 2--ALUMINUM LAKE
levothyroxine sodium drug variants containing FD&C BLUE NO. 2--ALUMINUM LAKE
levothyroxine sodium drug variants not containing FD&C BLUE NO. 2--ALUMINUM LAKE
Excipient focus: FD&C RED NO. 40
levothyroxine sodium drug variants containing FD&C RED NO. 40
levothyroxine sodium drug variants not containing FD&C RED NO. 40
Excipient focus: FD&C YELLOW NO. 5
levothyroxine sodium drug variants containing FD&C YELLOW NO. 5
levothyroxine sodium drug variants not containing FD&C YELLOW NO. 5
Excipient focus: FD&C YELLOW NO. 6
levothyroxine sodium drug variants containing FD&C YELLOW NO. 6
levothyroxine sodium drug variants not containing FD&C YELLOW NO. 6
Excipient focus: FD&C YELLOW NO. 6 ALUMINUM LAKE
levothyroxine sodium drug variants containing FD&C YELLOW NO. 6 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | levothyroxine sodium | 0904-6949 |
| Cardinal Health 107 LLC | levothyroxine sodium | 55154-3558 |
| Cardinal Health 107 LLC | levothyroxine sodium | 55154-5362 |
| >Company | >Ingredient | >NDC |
levothyroxine sodium drug variants not containing FD&C YELLOW NO. 6 ALUMINUM LAKE
Excipient focus: GELATIN
levothyroxine sodium drug variants containing GELATIN
levothyroxine sodium drug variants not containing GELATIN
Excipient focus: GLYCERIN
levothyroxine sodium drug variants containing GLYCERIN
levothyroxine sodium drug variants not containing GLYCERIN
Excipient focus: HYDROCHLORIC ACID
levothyroxine sodium drug variants containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | levothyroxine sodium | 24201-002 |
| Fresenius Kabi USA LLC | levothyroxine sodium | 63323-885 |
| >Company | >Ingredient | >NDC |
levothyroxine sodium drug variants not containing HYDROCHLORIC ACID
Excipient focus: KI203
levothyroxine sodium drug variants containing KI203
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | levothyroxine sodium | 50090-7648 |
| A-S Medication Solutions | levothyroxine sodium | 50090-7649 |
| >Company | >Ingredient | >NDC |
levothyroxine sodium drug variants not containing KI203
Excipient focus: LACTOSE
levothyroxine sodium drug variants containing LACTOSE
levothyroxine sodium drug variants not containing LACTOSE
Excipient focus: LACTOSE MONOHYDRATE
levothyroxine sodium drug variants containing LACTOSE MONOHYDRATE
levothyroxine sodium drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM OXIDE
levothyroxine sodium drug variants containing MAGNESIUM OXIDE
levothyroxine sodium drug variants not containing MAGNESIUM OXIDE
Excipient focus: MAGNESIUM STEARATE
levothyroxine sodium drug variants containing MAGNESIUM STEARATE
levothyroxine sodium drug variants not containing MAGNESIUM STEARATE
Excipient focus: MALTODEXTRIN
levothyroxine sodium drug variants containing MALTODEXTRIN
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | levothyroxine sodium | 59651-554 |
| >Company | >Ingredient | >NDC |
levothyroxine sodium drug variants not containing MALTODEXTRIN
Excipient focus: MANNITOL
levothyroxine sodium drug variants containing MANNITOL
levothyroxine sodium drug variants not containing MANNITOL
Excipient focus: METHYLPARABEN SODIUM
levothyroxine sodium drug variants containing METHYLPARABEN SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc | levothyroxine sodium | 52652-1950 |
| VistaPharm Inc | levothyroxine sodium | 66689-105 |
| Oliva Therapeutics LLC | levothyroxine sodium | 82685-360 |
| >Company | >Ingredient | >NDC |
levothyroxine sodium drug variants not containing METHYLPARABEN SODIUM
Excipient focus: MICROCRYSTALLINE CELLULOSE 101
levothyroxine sodium drug variants containing MICROCRYSTALLINE CELLULOSE 101
| Company | Ingredient | NDC |
|---|---|---|
| Preferred Pharmaceuticals Inc | levothyroxine sodium | 68788-4005 |
| >Company | >Ingredient | >NDC |
levothyroxine sodium drug variants not containing MICROCRYSTALLINE CELLULOSE 101
Excipient focus: POVIDONE
levothyroxine sodium drug variants containing POVIDONE
levothyroxine sodium drug variants not containing POVIDONE
Excipient focus: POVIDONE K29/32
levothyroxine sodium drug variants containing POVIDONE K29/32
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | levothyroxine sodium | 54868-4602 |
| >Company | >Ingredient | >NDC |
levothyroxine sodium drug variants not containing POVIDONE K29/32
Excipient focus: POVIDONE K30
levothyroxine sodium drug variants containing POVIDONE K30
levothyroxine sodium drug variants not containing POVIDONE K30
Excipient focus: POVIDONES
levothyroxine sodium drug variants containing POVIDONES
levothyroxine sodium drug variants not containing POVIDONES
Excipient focus: RED 27
levothyroxine sodium drug variants containing RED 27
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | levothyroxine sodium | 50090-5654 |
| A-S Medication Solutions | levothyroxine sodium | 50090-6573 |
| >Company | >Ingredient | >NDC |
levothyroxine sodium drug variants not containing RED 27
Excipient focus: RED 30
levothyroxine sodium drug variants containing RED 30
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | levothyroxine sodium | 50090-5654 |
| >Company | >Ingredient | >NDC |
levothyroxine sodium drug variants not containing RED 30
Excipient focus: SILICA
levothyroxine sodium drug variants containing SILICA
levothyroxine sodium drug variants not containing SILICA
Excipient focus: SILICON DIOXIDE
levothyroxine sodium drug variants containing SILICON DIOXIDE
levothyroxine sodium drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM BICARBONATE
levothyroxine sodium drug variants containing SODIUM BICARBONATE
levothyroxine sodium drug variants not containing SODIUM BICARBONATE
Excipient focus: SODIUM CHLORIDE
levothyroxine sodium drug variants containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | levothyroxine sodium | 24201-002 |
| Fresenius Kabi USA LLC | levothyroxine sodium | 63323-885 |
| >Company | >Ingredient | >NDC |
levothyroxine sodium drug variants not containing SODIUM CHLORIDE
Excipient focus: SODIUM HYDROXIDE
levothyroxine sodium drug variants containing SODIUM HYDROXIDE
levothyroxine sodium drug variants not containing SODIUM HYDROXIDE
Excipient focus: SODIUM IODIDE
levothyroxine sodium drug variants containing SODIUM IODIDE
| Company | Ingredient | NDC |
|---|---|---|
| Fresenius Kabi USA LLC | levothyroxine sodium | 63323-885 |
| >Company | >Ingredient | >NDC |
levothyroxine sodium drug variants not containing SODIUM IODIDE
Excipient focus: SODIUM LAURYL SULFATE
levothyroxine sodium drug variants containing SODIUM LAURYL SULFATE
levothyroxine sodium drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
levothyroxine sodium drug variants containing SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
levothyroxine sodium drug variants not containing SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A
levothyroxine sodium drug variants containing SODIUM STARCH GLYCOLATE TYPE A
| Company | Ingredient | NDC |
|---|---|---|
| Camber Pharmaceuticals Inc | levothyroxine sodium | 31722-284 |
| Ascent Pharmaceuticals Inc | levothyroxine sodium | 43602-417 |
| XLCare Pharmaceuticals Inc | levothyroxine sodium | 72865-236 |
| >Company | >Ingredient | >NDC |
levothyroxine sodium drug variants not containing SODIUM STARCH GLYCOLATE TYPE A
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
levothyroxine sodium drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
levothyroxine sodium drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: SODIUM STEARYL FUMARATE
levothyroxine sodium drug variants containing SODIUM STEARYL FUMARATE
levothyroxine sodium drug variants not containing SODIUM STEARYL FUMARATE
Excipient focus: STARCH, CORN
levothyroxine sodium drug variants containing STARCH, CORN
levothyroxine sodium drug variants not containing STARCH, CORN
Excipient focus: SUCROSE
levothyroxine sodium drug variants containing SUCROSE
levothyroxine sodium drug variants not containing SUCROSE
Excipient focus: TALC
levothyroxine sodium drug variants containing TALC
levothyroxine sodium drug variants not containing TALC
Excipient focus: TROMETHAMINE
levothyroxine sodium drug variants containing TROMETHAMINE
| Company | Ingredient | NDC |
|---|---|---|
| Fresenius Kabi USA LLC | levothyroxine sodium | 63323-885 |
| >Company | >Ingredient | >NDC |
levothyroxine sodium drug variants not containing TROMETHAMINE
Excipient focus: WATER
levothyroxine sodium drug variants containing WATER
levothyroxine sodium drug variants not containing WATER
Excipient focus: ZEA MAYS
levothyroxine sodium drug variants containing ZEA MAYS
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | levothyroxine sodium | 50090-7565 |
| A-S Medication Solutions | levothyroxine sodium | 50090-7566 |
| A-S Medication Solutions | levothyroxine sodium | 50090-7767 |
| >Company | >Ingredient | >NDC |
levothyroxine sodium drug variants not containing ZEA MAYS
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links